miR-4284 alleviates calcium oxalate monohydrate crystal-induced renal tubular epithelial injury in HK-2 cells via directly targeting MMP10
Functional & Integrative Genomics · 2026-12 · 26 (1)
DOI: 10.1007/s10142-026-02065-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Functional & Integrative Genomics, online erschienen am 29.10.2026. Verfasst von Zenglin Cui und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Affiliated Hospital of Xuzhou Medical University, No. 99, Huaihai West Road, Quanshan District, Xuzhou, 221002, China. Hauptthemen laut MEDLINE: MicroRNAs, Calcium Oxalate, Epithelial Cells, Kidney Tubules. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Open Funding Project of Jiangsu Provincial Key Laboratory of New Drug Research and Clinical Pharmacy.
Abstract (Originalsprache)
Calcium oxalate monohydrate (COM) nephrolithiasis has a high global incidence and postoperative recurrence. The study was to investigate miR-4284's protective role and its targeting relationship with MMP10 in COM-induced HK-2 cell damage. HK-2 human renal tubular epithelial cells were exposed to COM crystals to establish an in vitro injury model. miR-4284 mimics and MMP10 overexpression plasmids were transfected for functional and rescue experiments. We adopted RT-qPCR, CCK-8, flow cytometry, LDH assay, ELISA, oxidative stress detection, western blot and dual-luciferase reporter assay to measure cell activity, apoptosis, inflammatory factors, antioxidant levels, tight junction proteins and target gene binding. COM treatment decreased miR-4284 expression and upregulated MMP10. miR-4284 improved cell viability, reduced apoptosis and LDH release. It suppressed inflammatory response and oxidative stress, and rescued Occludin, ZO-1 and E-Cadherin expression. Dual-luciferase assays confirmed direct binding between miR-4284 and MMP10 3'UTR. MMP10 overexpression abolished all protective phenotypes mediated by miR-4284. miR-4284 alleviates COM-triggered HK-2 cell injury by directly inhibiting MMP10. The miR‑4284/MMP10 axis identified in the HK‑2 in‑vitro cell model provides a preliminary mechanistic clue for understanding COM‑induced tubular injury, although its clinical relevance requires further validation in animal models and human specimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Affiliated Hospital of Xuzhou Medical University, No. 99, Huaihai West Road, Quanshan District, Xuzhou, 221002, China.
- Department of Urology, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, 450000, China.
- Department of Urology, The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou First People's Hospital, Xuzhou, 221002, China.
- Department of Urology, Xuzhou Renci Hospital, Xuzhou, 221000, China.
- Department of Urology, The Affiliated Hospital of Xuzhou Medical University, No. 99, Huaihai West Road, Quanshan District, Xuzhou, 221002, China. JQ_Wang_xz@163.com.
Förderung
- Open Funding Project of Jiangsu Provincial Key Laboratory of New Drug Research and Clinical Pharmacy
Zitieren
APA
Cui, Z., Zhang, Y., Li, Z., Wang, K., & Wang, J. (2026). miR-4284 alleviates calcium oxalate monohydrate crystal-induced renal tubular epithelial injury in HK-2 cells via directly targeting MMP10. Functional & Integrative Genomics, 26(1). https://doi.org/10.1007/s10142-026-02065-x
Vancouver
Cui Z, Zhang Y, Li Z, Wang K, Wang J. miR-4284 alleviates calcium oxalate monohydrate crystal-induced renal tubular epithelial injury in HK-2 cells via directly targeting MMP10. Functional & Integrative Genomics. 2026;26(1). doi:10.1007/s10142-026-02065-x
BibTeX
@article{Cui2026,
author = {Cui, Zenglin and Zhang, Yijing and Li, Zixiang and Wang, Kun and Wang, Junqi},
title = {miR-4284 alleviates calcium oxalate monohydrate crystal-induced renal tubular epithelial injury in HK-2 cells via directly targeting MMP10},
journal = {Functional & Integrative Genomics},
year = {2026},
volume = {26},
number = {1},
doi = {10.1007/s10142-026-02065-x}
}
EUVIMED